diabetology

Although several kinds of proteins are known to form heart amyloid, this is the first time found prion protein amyloid in heart muscle and also found to cause the heart to malfunction, says Dr. Chesebro. This is exciting for cardiologists, Dr. This study links the two areas of research. .

In this previous research were signs of prion protein amyloid around blood vessels prominent in the mouse brain. ‘s newly reported study, researchers found at the Scripps similar amyloid in the heart muscle. Then the help of Kirk Knowlton, Chief, Division of Cardiology assured from the University of California, San Diego, who studies the effect of prion protein amyloid on mouse heart function discovers that it decreases the heart’s ability to pump blood. Continue reading

According to Dr. Buckley, an aortic aneurysm a bulge in one section of the aorta, the body’s main artery. The aorta takes oxygenated blood from the heart to the rest of the body. Lead to death.tion with the aneurysm is overstretched and weak, it can burst. If the aorta bursts, it can cause severe bleeding that can quickly lead to death.

An advantage in repairing aneurysms in patients with difficult arterial anatomy Buckley went on to say that the device of a graft with an outer self-expanding support structure that is both flexible and robust is it through a small incision in the patient’s groin was introduced by means a catheter,. Passage and access through narrow or hostile arterial anatomy.. The patient who underwent the procedure for the live transmission in Brazil was suffering from an aneurysm of the abdominal aorta and an endograft was used to repair it. Continue reading

ICON has operations in Japan since 1995 and offers a broad range of clinical development services and temporary workers from its offices in Tokyo and Osaka. Commenting on the alliance, said Alan Morgan, ICON Group President, Clinical Research Services, Japan is a major center for clinical research and ICON well-established presence well-established presence Recent changes in the regulatory environment that a growing number has approximately 1,000 employees companies are looking to run development projects both at the national and pan regional basis.

As a contraceptive method is tested as a contraceptive in clinical studies in the U.S., according the Inquirer (Philadelphia Inquirer.. In September 2004,e III Microbicide Trial In NigeriaCellegy Pharmaceuticals on Monday announced that it has completed Phase III clinical trials in Nigeria on the microbicide Savvy, the Philadelphia Inquirer reports was the study in September 2004, began enrolling participants of the 2152 women in the study. Participated, was half Savvy gel given and half were the women gel. The women used the gel vaginally prior to each act of intercourse. Continue reading